#vaccine research

The vaccine, dubbed VIR-1388, is designed to stimulate the production of T cells to fight HIV.

U.S. syphilis incidence has increased since 2000, with an escalating toll in medically underserved populations.

Funding includes $1 billion for vaccine trials, $326 million for a new monoclonal antibody and $100 million for novel technologies.

A personalized melanoma vaccine enters a Phase III study, while a pancreatic cancer vaccine moves on to Phase II.

Researchers are working on vaccines that will target multiple flu or coronavirus strains.

Researchers are working on a cure for hepatitis B and a vaccine and long-acting antivirals for hepatitis C.

TB is one of the world’s deadliest diseases and the leading killer of people with HIV.

The experimental vaccine regimen trains the immune system to produce broadly neutralizing antibodies that target HIV.

The Jynneos monkeypox vaccine is highly effective, but two doses are needed for optimal protection.

Experimental flu vaccine, designed to elicit immunity against a broad range of influenza viruses, performed well in a small trial.

Moderna and Merck’s personalized neoantigen vaccine plus checkpoint inhibitor lowered the risk of disease progression after surgery by 44%.

Researchers are exploring novel strategies to help the immune system produce broadly neutralizing antibodies.

Worldwide, TB is one of the leading causes of death for people with HIV.

The experimental vaccine trains the immune system to recognize HER2 proteins on breast tumors.

Vaccines are tested for safety, but like all medical products, they can sometimes cause side effects.

Researchers halt the Mosaico study after an experimental vaccine was found to be safe but not effective against HIV.